![David Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
David Gordon served as the Chief Medical Officer at Aclaris Therapeutics, Inc. from 2018 to 2022.
Prior to that, he was the SVP and Head of Dermatology Research & Development at GSK Plc from 2016 to 2018.
Dr. Gordon earned a doctorate degree from the University of Aberdeen.
Former positions of David Gordon
| Companies | Position | End |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 07/01/2022 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/03/2018 |
Training of David Gordon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Aberdeen
 University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- David Gordon
